30-day FRN, NRC Request for Sodium Iodide I-131 Treatment and Patient Release Information

35990

Federal Register / Vol. 80, No. 120 / Tuesday, June 23, 2015 / Notices

Federal Register on October 22, 2003
(68 FR 60422). The licensee affirmed the
applicability of the model NSHC
determination in its application dated
July 24, 2014.
Date of issuance: May 28, 2015.
Effective date: As of the date of
issuance and shall be implemented
within 60 days of issuance.
Amendment No.: 99. A publiclyavailable version is in ADAMS under
Accession No. ML15092A761;
documents related to this amendment
are listed in the Safety Evaluation
enclosed with the amendment.
Facility Operating License No. NPF–
90: Amendment revised the Facility
Operating License and Technical
Specifications.
Date of initial notice in Federal
Register: September 30, 2014 (79 FR
58827).
The Commission’s related evaluation
of the amendment is contained in a
Safety Evaluation dated May 28, 2015.
NSHC determination comments
received: No.
Dated at Rockville, Maryland, this 12th day
of June 2015.
For the Nuclear Regulatory Commission.
A. Louise Lund,
Acting Director, Division of Operating Reactor
Licensing, Office of Nuclear Reactor
Regulation.
[FR Doc. 2015–15275 Filed 6–22–15; 8:45 am]
BILLING CODE 7590–01–P

NUCLEAR REGULATORY
COMMISSION
[NRC–2015–0020]

Information Collection: NRC Request
for Sodium Iodide I–131 Treatment and
Patient Release Information
Nuclear Regulatory
Commission.
ACTION: Notice of submission to the
Office of Management and Budget;
request for comment.
AGENCY:

The U.S. Nuclear Regulatory
Commission (NRC) has recently
submitted a proposed collection of
information to the Office of
Management and Budget (OMB) for
review. The information collection is
entitled, ‘‘NRC Request for Sodium
Iodide I–131 Treatment and Patient
Release Practices.’’
DATES: Submit comments by July 23,
2015.

mstockstill on DSK4VPTVN1PROD with NOTICES

SUMMARY:

Submit comments directly
to the OMB reviewer at: Vlad Dorjets,
Desk Officer, Office of Information and
Regulatory Affairs, (3150–XXXX),
NEOB–10202, Office of Management

ADDRESSES:

VerDate Sep<11>2014

18:39 Jun 22, 2015

Jkt 235001

and Budget, Washington, DC 20503;
telephone: 202–395–7315, email:
Vladik_Dorjets@omb.eop.gov.
FOR FURTHER INFORMATION CONTACT:
Tremaine Donnell, NRC Clearance
Officer, U.S. Nuclear Regulatory
Commission, Washington, DC 20555–
0001; telephone: 301–415–6258; email:
INFOCOLLECTS.Resource@nrc.gov.
SUPPLEMENTARY INFORMATION:
I. Obtaining Information and
Submitting Comments
A. Obtaining Information
Please refer to Docket ID NRC 2015–
0020 when contacting the NRC about
the availability of information for this
action. You may obtain publiclyavailable information related to this
action by any of the following methods:
• Federal Rulemaking Web site: Go to
http://www.regulations.gov and search
for Docket ID NRC 2015–0020. A copy
of the collection of information and
related instructions may be obtained
without charge by accessing Docket ID
NRC 2015–0020 on this Web site.
• NRC’s Agencywide Documents
Access and Management System
(ADAMS): You may obtain publiclyavailable documents online in the
ADAMS Public Documents collection at
http://www.nrc.gov/reading-rm/
adams.html. To begin the search, select
‘‘ADAMS Public Documents’’ and then
select ‘‘Begin Web-based ADAMS
Search.’’ For problems with ADAMS,
please contact the NRC’s Public
Document Room (PDR) reference staff at
1–800–397–4209, 301–415–4737, or by
email to pdr.resource@nrc.gov. The
supporting statement and Patient
Release Federal Register Notice (FRN)
Soliciting Information is available in
ADAMS under Accession No.
ML15134A123.
• NRC’s PDR: You may examine and
purchase copies of public documents at
the NRC’s PDR, Room O1–F21, One
White Flint North, 11555 Rockville
Pike, Rockville, Maryland 20852.
• NRC’s Clearance Officer: A copy of
the collection of information and related
instructions may be obtained without
charge by contacting the NRC’s
Clearance Officer, Tremaine Donnell,
Office of Information Services, U.S.
Nuclear Regulatory Commission,
Washington, DC 20555–0001; telephone:
301–415–6258; email:
INFOCOLLECTS.Resource@NRC.GOV.
B. Submitting Comments
The NRC cautions you not to include
identifying or contact information that
you do not want to be publicly
disclosed in your comment submission.
The NRC posts all comment

PO 00000

Frm 00059

Fmt 4703

Sfmt 4703

submissions at http://
www.regulations.gov as well as entering
the comment submissions into ADAMS.
The NRC does not routinely edit
comment submissions to remove
identifying or contact information.
If you are requesting or aggregating
comments from other persons for
submission to the NRC, then you should
inform those persons not to include
identifying or contact information that
they do not want to be publicly
disclosed in their comment submission.
Your request should state that the NRC
does not routinely edit comment
submissions to remove such information
before making the comment
submissions available to the public or
entering the comment submissions into
ADAMS.
II. Background
Under the provisions of the
Paperwork Reduction Act of 1995 (44
U.S.C. chapter 35), the NRC recently
submitted a proposed collection of
information to OMB for review entitled,
‘‘NRC Request for Sodium Iodide I–131
Treatment and Patient Release
Practices.’’ The NRC hereby informs
potential respondents that an agency
may not conduct or sponsor, and that a
person is not required to respond to, a
collection of information unless it
displays a currently valid OMB control
number.
The NRC published an FRN with a 60day comment period on this information
collection on March 3, 2015; 80 FR
11471, entitled ‘‘NRC Request for
Sodium Iodide I–131 Treatment and
Patient Release Practices.’’
1. The title of the information
collection: ‘‘NRC Request for Sodium
Iodide I–131 Treatment and Patient
Release Practices.’’
2. OMB approval number: An OMB
control number has not yet been
assigned to this proposed information
collection.
3. Type of submission: New.
4. The form number if applicable: Not
Applicable.
5. How often the collection is required
or requested: Once.
6. Who will be required or asked to
respond: Medical professional
organizations, physicians, patients,
patient advocacy groups, NRC and
Agreement State medical use licensees,
Agreement States, and other interested
individuals who use, receive, license or
have interest in the use of I–131 sodium
iodide (hereafter referred to as ‘‘I–131’’)
for the treatment of thyroid conditions.

E:\FR\FM\23JNN1.SGM

23JNN1

Federal Register / Vol. 80, No. 120 / Tuesday, June 23, 2015 / Notices

mstockstill on DSK4VPTVN1PROD with NOTICES

7. The estimated number of annual
responses: A one-time collection
estimated to have 1,180 responses (620
medical community + 560 patients).
8. The estimated number of annual
respondents: 1,180 respondents (620
medical community + 560 patients).
9. An estimate of the total number of
hours needed annually to comply with
the information collection requirement
or request: 457.5 hours (255 medical
community + 202.5 patients).
10. Abstract: The NRC is requesting a
one-time information collection that
will be solicited in an FRN. The FRN
will have specific I–131 patient release
questions associated with: (1) Existing
Web sites that the responders believe
provide access to clear and consistent
patient information about I–131
treatment processes and procedures; (2)
information the responders believe
represent best practices used in making
informed decisions on releasing I–131
patients and stand alone or
supplemental voluntary patient/licensee
guidance acknowledgment forms, if
available; (3) an existing set of
guidelines that the responder developed
or received that provides instructions to
released patients; and (4) an existing
guidance brochure that the responder
believes would be acceptable for
nationwide distribution. The responses
will form the basis for patient release
guidance products developed in
response to the NRC’s April 28, 2014,
Staff Requirements—COMAMM–14–
0001/COMWDM–14–0001—
‘‘Background and Proposed Direction to
NRC Staff to Verify Assumptions Made
Concerning Patient Release Guidance.’’
The Commission, based on information
from patients and patient advocacy
groups, questioned the availability of
clear, consistent, patient friendly and
timely patient release information and
directed the staff to work with a wide
variety of stakeholders when developing
new guidance products. This
information collection effort was
developed to gain input from as many
stakeholders as possible. The NRC
solicitation in the Federal Register is to
obtain existing information from a
variety of stakeholders.
Dated at Rockville, Maryland, this 18th day
of June, 2015.
For the Nuclear Regulatory Commission.
Tremaine Donnell,
NRC Clearance Officer, Office of Information
Services.
[FR Doc. 2015–15391 Filed 6–22–15; 8:45 am]
BILLING CODE 7590–01–P

VerDate Sep<11>2014

18:39 Jun 22, 2015

Jkt 235001

NUCLEAR REGULATORY
COMMISSION
[NRC–2015–0147]

Information Collection: Environmental
Protection Regulations for Domestic
Licensing and Related Regulatory
Functions
Nuclear Regulatory
Commission.
ACTION: Renewal of existing information
collection; request for comment.
AGENCY:

The U.S. Nuclear Regulatory
Commission (NRC) invites public
comment on the renewal of Office of
Management and Budget (OMB)
approval for an existing collection of
information. The information collection
is entitled, ‘‘Environmental Protection
Regulations for Domestic Licensing and
Related Regulatory Functions.’’
DATES: Submit comments by August 24,
2015. Comments received after this date
will be considered if it is practical to do
so, but the Commission is able to ensure
consideration only for comments
received on or before this date.
ADDRESSES: You may submit comments
by any of the following methods:
• Federal Rulemaking Web site: Go to
http://www.regulations.gov and search
for Docket ID NRC–2015–0147. Address
questions about NRC dockets to Carol
Gallagher; telephone: 301–287–3422;
email: Carol.Gallagher@nrc.gov. For
technical questions, contact the
individual listed in the FOR FURTHER
INFORMATION CONTACT section of this
document.
• Mail comments to: Tremaine
Donnell, Office of Information Services,
Mail Stop: T–5 F53, U.S. Nuclear
Regulatory Commission, Washington,
DC 20555–0001.
For additional direction on obtaining
information and submitting comments,
see ‘‘Obtaining Information and
Submitting Comments’’ in the
SUPPLEMENTARY INFORMATION section of
this document.
FOR FURTHER INFORMATION CONTACT:
Tremaine Donnell, Office of Information
Services, U.S. Nuclear Regulatory
Commission, Washington, DC 20555–
0001; telephone: 301–415–6258; email:
INFOCOLLECTS.Resource@NRC.GOV.
SUPPLEMENTARY INFORMATION:
SUMMARY:

I. Obtaining Information and
Submitting Comments
A. Obtaining Information
Please refer to Docket ID NRC–2015–
0147 when contacting the NRC about
the availability of information for this
action. You may obtain publicly-

PO 00000

Frm 00060

Fmt 4703

Sfmt 4703

35991

available information related to this
action by any of the following methods:
• Federal rulemaking Web site: Go to
http://www.regulations.gov and search
for Docket ID NRC–2015–0147.
• NRC’s Agencywide Documents
Access and Management System
(ADAMS): You may obtain publiclyavailable documents online in the
ADAMS Public Documents collection at
http://www.nrc.gov/reading-rm/
adams.html. To begin the search, select
‘‘ADAMS Public Documents’’ and then
select ‘‘Begin Web-based ADAMS
Search.’’ For problems with ADAMS,
please contact the NRC’s Public
Document Room (PDR) reference staff at
1–800–397–4209, 301–415–4737, or by
email to pdr.resource@nrc.gov. The
supporting statement is available in
ADAMS under Accession No.
ML15106A720.
• NRC’s PDR: You may examine and
purchase copies of public documents at
the NRC’s PDR, Room O1–F21, One
White Flint North, 11555 Rockville
Pike, Rockville, Maryland 20852.
• NRC’s Clearance Officer: A copy of
the collection of information and related
instructions may be obtained without
charge by contacting NRC’s Clearance
Officer, Tremaine Donnell, Office of
Information Services, U.S. Nuclear
Regulatory Commission, Washington,
DC 20555–0001; telephone: 301–415–
6258; email: INFOCOLLECTS.Resource@
NRC.GOV.
B. Submitting Comments
Please include Docket ID NRC–2015–
0147 in your comment submission.
The NRC cautions you not to include
identifying or contact information in
comment submissions that you do not
want to be publicly disclosed in your
comment submission. The NRC will
post all comment submissions at
http://www.regulations.gov as well as
enter the comment submissions into
ADAMS, and the NRC does not
routinely edit comment submissions to
remove identifying or contact
information.
If you are requesting or aggregating
comments from other persons for
submission to the NRC, then you should
inform those persons not to include
identifying or contact information that
they do not want to be publicly
disclosed in their comment submission.
Your request should state that the NRC
does not routinely edit comment
submissions to remove such information
before making the comment
submissions available to the public or
entering the comment into ADAMS.

E:\FR\FM\23JNN1.SGM

23JNN1